Amyloidosis Research Consortium UK is a dissolved company incorporated on 27 October 2017 with the registered office located in Edinburgh, City of Edinburgh. Amyloidosis Research Consortium UK was registered 8 years ago.
Application to strike the company off the register
Submitted on 15 Oct 2019
First Gazette notice for compulsory strike-off
Submitted on 24 Sep 2019
Registered office address changed from 22 (G1) Forth Street Edinburgh EH1 3LH Scotland to Lindsays Caledonian Exchange 19a Canning Street Edinburgh EH3 8HE on 17 July 2019
Submitted on 17 Jul 2019
Confirmation statement made on 26 October 2018 with no updates
Submitted on 12 Nov 2018
Appointment of Mr David Thomson as a director on 18 May 2018
Submitted on 21 May 2018
Current accounting period extended from 31 October 2018 to 31 December 2018